Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Initiator Pharma A/S
A/S
Active
Advertising protection
CVR 37663808
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 10 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Initiator Pharma A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-12M
-24M
-35M
-47M
2021: 0M
0M
2021
2022: -38M
-38M
2022
2023: -23M (+39% vs 2022)
-23M
+39%
2023
2024: -11M (+52% vs 2023)
-11M
+52%
2024
2025: -15M (-36% vs 2024)
-15M
-36%
2025
EBITDA
DKK millions
0M
-13M
-26M
-39M
-52M
2021: 0M
0M
2021
2022: -42M
-42M
2022
2023: -27M (+36% vs 2022)
-27M
+36%
2023
2024: -15M (+44% vs 2023)
-15M
+44%
2024
2025: -18M (-20% vs 2024)
-18M
-20%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
-14.828
-11.073
-23.413
-38.425
-22
Staff expenses
-2.953
-3.427
-3.617
-3.315
-1
EBITDA
-17.781
-14.502
-27.030
-41.740
-23
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-17.781
-14.502
-27.030
-41.740
-23
Net financials
1.085
-333
-677
-2.392
-1
Profit before tax
-16.696
-14.836
-27.707
-44.132
-24
Tax
-3.009
-1.904
-4.834
-5.677
-3
Net profit
-13.687
-12.932
-22.873
-38.455
-21
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
33.759
15.835
29.786
48.345
54
Equity
29.546
14.782
11.162
34.023
35
Long-term debt
2.149
0
15.437
12.577
13
Short-term debt
2.064
1.053
3.187
1.745
5
Total debt
4.213
1.053
18.624
14.322
5
Financial ratios
5-year trend
EBITDA margin (of gross profit)
<−999 %
This company
2021
2025
Equity ratio
87,5 %
This company
38,2 %
Market median
This company
Market median
129% above market
2021
2025
Return on equity
-46,3 %
This company
18,4 %
Market median
This company
Market median
352% below market
2021
2025
Net profit margin (of gross profit)
<−999 %
This company
2021
2025
Asset turnover (of gross profit)
-0,44×
This company
2021
2025
Debt / equity
0,14×
This company
0,62×
Market median
This company
Market median
77% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Initiator Pharma A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
